Topical medication instillation techniques for glaucoma. (Q34551634)

7 June 2018

title

Topical medication instillation techniques for glaucoma. (English)

1 reference

7 June 2018

author name string

Li Xu

series ordinal

1 reference

7 June 2018

Xuemei Wang

series ordinal

1 reference

7 June 2018

Meijing Wu

series ordinal

1 reference

7 June 2018

publication date

20 February 2017

1 reference

7 June 2018

Cochrane Database of Systematic Reviews

published in

1 reference

7 June 2018

volume

1 reference

7 June 2018

page(s)

CD010520

1 reference

7 June 2018

Consensus on Outcome Measures for Glaucoma Effectiveness Trials: Results From a Delphi and Nominal Group Technique Approaches.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Outcomes in Cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

An evidence-based review of prognostic factors for glaucomatous visual field progression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

What comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Definition of glaucoma: clinical and experimental concepts

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Natural history of glaucoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Natural history of open-angle glaucoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Risk factors for glaucoma onset and progression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

The management of glaucoma and intraocular hypertension: current approaches and recent advances

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Current management of glaucoma and the need for complete therapy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

How to identify randomized controlled trials in MEDLINE: ten years on

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

The number of people with glaucoma worldwide in 2010 and 2020

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Glaucoma and its treatment: a review.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Management of glaucoma: focus on pharmacological therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

The effects of nasolacrimal canal blockage on topical medications for glaucoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

The epidemiology and control of open angle glaucoma: a population-based perspective

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Number of people with glaucoma worldwide

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Potential side effects of timolol therapy in the treatment of glaucoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Plasma timolol in glaucoma patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Ophthalmic drug delivery systems

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Clinical Implications of Reported Timolol-lnduced Side Effects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Topical ocular drug delivery: recent developments and future challenges

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Punctal occlusion and topical medications for glaucoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Systemic side effects of glaucoma medications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Drug delivery systems for topical ophthalmic medication

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Extraocular fluid dynamics: how best to apply topical ocular medication

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Pilocarpine medication in open-angle glaucoma. A study using pilocarpine eyedrops and an ocular therapeutic system

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Primary angle-closure glaucoma. Oculometry, epidemiology, and genetics in a high risk population

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy.

7 July 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

Adherence improvement in Dutch glaucoma patients: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

Silicone punctal plugs as an adjunctive therapy for open-angle glaucoma and ocular hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

The safety and efficacy of timolol 0.5% in xanthan gum versus timolol gel forming solution 0.5%.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

Ophthalmic drug delivery systems--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

Causes and prevalence of visual impairment among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

Topical medication instillation techniques for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010520.PUB2

Xal-Ease: impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

[Ocular side effects of glaucoma treatment agents]

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Efficacy of silicone punctal plugs as adjuncts to topical pharmacotherapy of glaucoma--a pilot study. Punctal Plugs in Glaucoma Study Group.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5419432

Pump Infusion of Pilocarpine

27 October 2018

1 reference

12 December 2020

Therapeutic Index of Pilocarpine, Carbachol, and Timolol With Nasolacrimal Occlusion

1 reference

12 December 2020

Therapeutic Index of Epinephrine and Dipivefrin With Nasolacrimal Occlusion

1 reference

12 December 2020

Effect of nasolacrimal occlusion on timolol concentrations in the aqueous humor of the human eye

1 reference

12 December 2020

Evaluating eye drop instillation technique in glaucoma patients

1 reference

12 December 2020

Impact of eyelid closure on the intraocular pressure lowering effect of prostaglandins: a randomised controlled trial

1 reference

12 December 2020

[Alterations of intraocular pressure in comparison of self- and external-administered topical antiglaucomatosa during diurnal intraocular pressure measurements]

1 reference

12 December 2020

Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy

1 reference

12 December 2020

Does lacrimal duct occlusion decrease intraocular pressure in patients refractory to medical treatment for glaucoma? A randomized, sham-controlled, crossover trial

1 reference

12 December 2020

Effects of eyelid closure and nasolacrimal duct occlusion on the systemic absorption of ocular timolol in human subjects

1 reference

12 December 2020

Improper topical self-administration of ocular medication among patients with glaucoma

1 reference

12 December 2020

Side effects of topical ocular timolol

1 reference

12 December 2020

Facilitating patient compliance in glaucoma therapy

1 reference

12 December 2020

Improving the therapeutic index of topically applied ocular drugs

1 reference

12 December 2020

10.1002/14651858.CD010520.PUB2

Identifiers

DOI

1 reference

7 June 2018

PMC publication ID

5419432

1 reference

7 June 2018

PubMed publication ID

28218404

1 reference

7 June 2018